CAS: 203192-01-2
MN58b
CAS:203192-01-2
MN58b is a selective inhibitor of choline kinase α (CHKα).
Formula:
C32H40Br2N4
Purity:
97.46%
Color and Shape:
Solid
Molecular weight:
640.49
Ref: TM-T12085
| 1mg | 290.00 € | |
| 5mg | 709.00 € | |
| 10mg | 916.00 € | |
| 25mg | 1,440.00 € | |
| 50mg | 1,838.00 € | |
| 100mg | 2,599.00 € | |
| 1ml*10 (DMSO) | 889.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
![Pyridinium, 1,1'-[1,4-butanediylbis(4,1-phenylenemethylene)]bis[4-(dimethylamino)-, bromide (1:2)](https://static.cymitquimica.com/products/AN/thumb/AG01JUI8.jpg)
Pyridinium, 1,1'-[1,4-butanediylbis(4,1-phenylenemethylene)]bis[4-(dimethylamino)-, bromide (1:2)
CAS:203192-01-2
Formula:
C32H40Br2N4
Purity:
98%
Color and Shape:
Solid
Molecular weight:
640.4948
Ref: AN-AG01JUI8
| 25mg | 165.00 € | |
| 50mg | 198.00 € | |
| 100mg | 334.00 € |
Estimated delivery in United States, on Tuesday 21 May 2024
MN58b
CAS:203192-01-2
MN58b is a novel chemotherapeutic drug that is clinically relevant to the treatment of autoimmune …
Formula:
C32H40Br2N4
Purity:
Min. 95%
Molecular weight:
640.5 g/mol
Ref: 3D-DIA19201
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire |
Estimated delivery in United States, on Monday 1 Jul 2024
